IL188481A0 - New salt ii - Google Patents
New salt iiInfo
- Publication number
- IL188481A0 IL188481A0 IL188481A IL18848107A IL188481A0 IL 188481 A0 IL188481 A0 IL 188481A0 IL 188481 A IL188481 A IL 188481A IL 18848107 A IL18848107 A IL 18848107A IL 188481 A0 IL188481 A0 IL 188481A0
- Authority
- IL
- Israel
- Prior art keywords
- new salt
- salt
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0501770 | 2005-08-02 | ||
PCT/SE2006/000921 WO2007015667A1 (en) | 2005-08-02 | 2006-07-31 | New salt ii |
Publications (1)
Publication Number | Publication Date |
---|---|
IL188481A0 true IL188481A0 (en) | 2008-04-13 |
Family
ID=37708912
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL188481A IL188481A0 (en) | 2005-08-02 | 2007-12-27 | New salt ii |
Country Status (16)
Country | Link |
---|---|
US (1) | US20080280951A1 (en) |
EP (1) | EP1922305A1 (en) |
JP (1) | JP2009503065A (en) |
KR (1) | KR20080032144A (en) |
CN (1) | CN101238102A (en) |
AR (1) | AR055107A1 (en) |
AU (1) | AU2006276345A1 (en) |
BR (1) | BRPI0614432A2 (en) |
CA (1) | CA2617404A1 (en) |
IL (1) | IL188481A0 (en) |
MX (1) | MX2008001112A (en) |
NO (1) | NO20081081L (en) |
TW (1) | TW200738635A (en) |
UY (1) | UY29712A1 (en) |
WO (1) | WO2007015667A1 (en) |
ZA (1) | ZA200800522B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200738634A (en) * | 2005-08-02 | 2007-10-16 | Astrazeneca Ab | New salt |
TW200825084A (en) | 2006-11-14 | 2008-06-16 | Astrazeneca Ab | New compounds 521 |
WO2008100202A1 (en) * | 2007-02-14 | 2008-08-21 | Astrazeneca Ab | A 2-f luorobenzoate salt and a 2, 6-dif luorobenzoate salt of n-{5-chloro-2- [ ( (2s) -3-{ [1- (4-chlorobenzyl)piperidin-4- yl ] amino } - 2 - hydroxy- 2 -me t hylpr opyl ) oxy] - 4 - hydroxyphenyl } acetamide |
GB0808709D0 (en) * | 2008-05-13 | 2008-06-18 | Astrazeneca Ab | New combination 295 |
CA2723981A1 (en) | 2008-05-13 | 2009-11-19 | Astrazeneca Ab | New compounds 273 |
GB0814729D0 (en) * | 2008-08-12 | 2008-09-17 | Argenta Discovery Ltd | New combination |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000031033A1 (en) * | 1998-11-20 | 2000-06-02 | F. Hoffmann-La Roche Ag | Piperidine ccr-3 receptor antagonists |
SE9900833D0 (en) * | 1999-03-09 | 1999-03-09 | Astra Ab | Novel combination |
CO5300399A1 (en) * | 2000-02-25 | 2003-07-31 | Astrazeneca Ab | HETEROCICLIOCS CONTAINING NITROGEN, PROCESS FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
GB0012260D0 (en) * | 2000-05-19 | 2000-07-12 | Astrazeneca Ab | Novel composition |
AR028947A1 (en) * | 2000-06-20 | 2003-05-28 | Astrazeneca Ab | NEW COMPOUNDS |
AR028948A1 (en) * | 2000-06-20 | 2003-05-28 | Astrazeneca Ab | NEW COMPOUNDS |
GB0021670D0 (en) * | 2000-09-04 | 2000-10-18 | Astrazeneca Ab | Chemical compounds |
SE0104251D0 (en) * | 2001-12-14 | 2001-12-14 | Astrazeneca Ab | Novel compounds |
TW200303304A (en) * | 2002-02-18 | 2003-09-01 | Astrazeneca Ab | Chemical compounds |
-
2006
- 2006-07-25 TW TW095127079A patent/TW200738635A/en unknown
- 2006-07-31 JP JP2008524933A patent/JP2009503065A/en active Pending
- 2006-07-31 CA CA002617404A patent/CA2617404A1/en not_active Abandoned
- 2006-07-31 MX MX2008001112A patent/MX2008001112A/en not_active Application Discontinuation
- 2006-07-31 AU AU2006276345A patent/AU2006276345A1/en not_active Abandoned
- 2006-07-31 CN CNA2006800284859A patent/CN101238102A/en active Pending
- 2006-07-31 BR BRPI0614432-2A patent/BRPI0614432A2/en not_active IP Right Cessation
- 2006-07-31 US US11/997,513 patent/US20080280951A1/en not_active Abandoned
- 2006-07-31 UY UY29712A patent/UY29712A1/en unknown
- 2006-07-31 EP EP06758094A patent/EP1922305A1/en not_active Withdrawn
- 2006-07-31 WO PCT/SE2006/000921 patent/WO2007015667A1/en active Application Filing
- 2006-07-31 KR KR1020087002809A patent/KR20080032144A/en not_active Application Discontinuation
- 2006-08-02 AR ARP060103360A patent/AR055107A1/en not_active Application Discontinuation
-
2007
- 2007-12-27 IL IL188481A patent/IL188481A0/en unknown
-
2008
- 2008-01-17 ZA ZA200800522A patent/ZA200800522B/en unknown
- 2008-02-29 NO NO20081081A patent/NO20081081L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2006276345A1 (en) | 2007-02-08 |
TW200738635A (en) | 2007-10-16 |
BRPI0614432A2 (en) | 2011-03-29 |
EP1922305A1 (en) | 2008-05-21 |
JP2009503065A (en) | 2009-01-29 |
WO2007015667A1 (en) | 2007-02-08 |
ZA200800522B (en) | 2008-12-31 |
AR055107A1 (en) | 2007-08-08 |
CN101238102A (en) | 2008-08-06 |
KR20080032144A (en) | 2008-04-14 |
MX2008001112A (en) | 2008-03-11 |
NO20081081L (en) | 2008-02-29 |
CA2617404A1 (en) | 2007-02-08 |
US20080280951A1 (en) | 2008-11-13 |
UY29712A1 (en) | 2007-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU0500920D0 (en) | New compounds | |
HU0500921D0 (en) | New compounds | |
HU0600293D0 (en) | New rosuvastatine salt | |
EP1934217A4 (en) | New compounds ii | |
ZA200800365B (en) | Substituted tetrahydroqulnolines | |
ZA200800522B (en) | New salt II | |
GB0506800D0 (en) | New uses | |
GB0518232D0 (en) | New methods | |
ZA200800515B (en) | New Salt I | |
ZA200800488B (en) | New Salt III | |
HU0501170D0 (en) | New compounds | |
HU0501168D0 (en) | New compounds | |
HU0500886D0 (en) | New compounds | |
HU0500879D0 (en) | New compounds | |
HU0500877D0 (en) | New compounds | |
EP1951694A4 (en) | Salt forms | |
HU0501166D0 (en) | New compounds | |
HU0500878D0 (en) | New compounds | |
GB0425955D0 (en) | Salt form | |
GB0511000D0 (en) | Novel salt | |
GB0427702D0 (en) | Novel salt | |
GB0501244D0 (en) | Novel quaternised salt | |
HU0900197D0 (en) | New olanzapine salt | |
GB0523845D0 (en) | Novel salts | |
GB0526668D0 (en) | New anti-viral-compounds |